首页> 外文期刊>Journal of Biochemical and Biophysical Methods >Denaturing high-performance liquid chromatography (DHPLC) is a highly sensitive, semi-automated method for identifying mutations in the TSC1 gene.
【24h】

Denaturing high-performance liquid chromatography (DHPLC) is a highly sensitive, semi-automated method for identifying mutations in the TSC1 gene.

机译:变性高效液相色谱(DHPLC)是鉴定TSC1基因突变的高度灵敏的半自动化方法。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Sensitive and automated methods for the detection of DNA sequence variation are required for a wide variety of genetic studies. Diagnostic testing in human genetic disorders is one application of such methods. Tuberous sclerosis complex (TSC) is an autosomal dominant familial tumor syndrome characterized by the development of benign tumors (hamartomas) in multiple organs (OMIM # 19110, #191092). There is a high frequency of sporadic cases and significant demand from patients and families for genetic testing information. Two TSC genes have been identified (TSC1 and TSC2) and together account for all cases [1,2]. Here we report our methods for DHPLC analysis of the TSC1 gene and demonstrate the high sensitivity of this method in a blinded analysis of 21 TSC patients with known TSC1 mutations. In this series, DHPLC detected 27/28 (96%) known TSC1 sequence variations. The only sequence variation not identified by DHPLC in this study is a mosaic case.
机译:各种各样的遗传研究都需要灵敏和自动化的方法来检测DNA序列变异。人类遗传疾病中的诊断测试是此类方法的一种应用。结节性硬化症(TSC)是常染色体显性家族性肿瘤综合症,其特征是多器官良性肿瘤(血管瘤)的发展(OMIM#19110,#191092)。散发病例的频率很高,患者和家属对基因检测信息的需求很高。已经鉴定出两个TSC基因(TSC1和TSC2),它们共同构成了所有病例[1,2]。在这里,我们报告了DSC分析TSC1基因的方法,并在对21个已知TSC1突变的TSC患者进行盲法分析中证明了该方法的高灵敏度。在该系列中,DHPLC检测到27/28(96%)个已知的TSC1序列变异。在这项研究中唯一未通过DHPLC鉴定的序列变异是镶嵌病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号